chrisvoncsefalvay/vaers-outcomes huggingface dataset:
failed to get the 2nd one/I lost track of getting the 2nd Shingles shot; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles. Previously administered products included Shingles vaccine (1st dose received) and COVID-19 Vaccine (Patient had to got COVID shots and then the booster dose.).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Additional Information: GSK Receipt Date: 04-AUG-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter reported that the patient received Shingles vaccine. The reporter stated that the patient did not received second dose because patient had to get the Covid vaccine and then the booster dose. The patient due to so many shots patient lost track of getting the second Shingles vaccine dose. The reporter stated that the patient definitely will get the Second dose. the patient never want to deal with shingles again. Follow-up would not possible as no contact details were available. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose, which led to incomplete course of vaccination.
PT REPORTS ONLY SORE ARM NOTHING UNUSUAL ON FIRST SHOT-2ND SHOT SHE REPORTS SEVERE REDNESS SWELLING AND PAIN (TYPICAL INJXN SITE RXN) LASTING 3-5 DAYS SHE ONLY TOOK OTC PAIN RELIEVERS AND CALLED NO ONE-SHE WENT TO MEDICAL CARE FOR TX FOR CONT. PAIN AROUND THE 5TH OF FEB.  SHE REPORTS ONLY TEMPORARY RELIEF FROM MASSAGE-MUSCLE RELAXERS-ADVIL-TYLENOL. "NOTHING RELIEVES PAIN IN SHOULDER AND UP TOWARD THE NECK" WORSENS W/ TENSION & STRESS
After 1st Dose (2/26/21, 3:50pm)- Pain in left arm appeared about 8 hours after injected and lasted for about 1-2 days. After 2nd Dose (3/22/21, 3:35pm)- Pain in left arm, fever (100.6 F), chills, headache, nausea, body aches (Severe pain in lower back and hips. Knees and elbows ached too. I assume the aches were associated with the fever b/c this often happens to me with fevers). All of these symptoms started around 3:30am 3/23/21 and lasted through 4-5 pm on 3/23/21. Only treatment was Acetaminophen Extra Strength, 2 pills taken around 2:30 pm on 3/23/21. Symptoms started improving 20 minutes after taking medication.  I stayed home from work on 3/23/21, but was able to return to work on 3/24/21. Felt great on 3/24/21. No symptoms.
Delayed reaction (After 6 weeks of Vaccine); Blotchy skin; High fever (6 weeks after shot)/fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Delayed reaction (After 6 weeks of Vaccine)), RASH MACULAR (Blotchy skin) and PYREXIA (High fever (6 weeks after shot)/fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Delayed reaction (After 6 weeks of Vaccine)), RASH MACULAR (Blotchy skin) and PYREXIA (High fever (6 weeks after shot)/fever). At the time of the report, VACCINATION COMPLICATION (Delayed reaction (After 6 weeks of Vaccine)), RASH MACULAR (Blotchy skin) and PYREXIA (High fever (6 weeks after shot)/fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reporterd by the reporter. No treatment medications were reported by the reporter.
Severe lower back pain, bloating in abdomen, muscular pain in abdomen, stomach discomfort,  neck pain, tiredness, and feeling of being disoriented.
Swelling/Pruritic rash. Swelling and pain. Ice-Tylenol Elocon 0.1-1 topical cream
Vaccine was not moved from freezer to fridge  at the 2 week mark.  CDC advised repeat dose and report VAERS
Vaccines MMR, IPV, DtaP given on 08/01/2006.  He has fever (101-102 F) for 48 hours afterward.  On 08/09/2006 he developed erythema multiforme which could only be related to the vaccines.
MIGRAINE; MY ARM FELT LIKE IT HAD TAKEN A BULLET; FEVER DURING THE NIGHT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced migraine, my arm felt like it had taken a bullet, and fever during the night. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the migraine, my arm felt like it had taken a bullet and fever during the night was not reported. This report was non-serious.
Report 20010087151 described hives in an 8 year old male who received hep B vaccine. Allergies, medical history, and concomitant medicaitons were not specified. On an unspecified date, the vaccinee received his first dose of Engerix B. Subsequently, he experienced "hives on trunk." As of 04/04/2001, the outcome of the event is unknown.
Vaccine administered after after 4 temperature excursions; Vaccine administered after after 4 temperature excursions; No aderse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 023H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions), POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions) and NO ADVERSE EVENT (No aderse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No aderse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after after 4 temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after after 4 temperature excursions).    No concomitant medications were reported.   It was unknown if patient receive any other vaccines in the 4 weeks prior to COVID-19 vaccine.  It was reported that vaccine was moved from freezer to refrigerator on 12/2/22 of the ten vials in question 43 injections were given and 7 doses were wasted. Vaccine administered after after 4 temperature excursions.  No treatment medication was provided.   This case was linked to US-MODERNATX, INC.-MOD-2022-689222 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-689222:Master case
Dizziness x 3 day, nausea w/o vomiting, perioral fever blisters lasting 2 weeks duration.
feeling dizzy; vertigo/spinning; couldn't walk normally; couldn't do anything; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (feeling dizzy), VERTIGO (vertigo/spinning), GAIT DISTURBANCE (couldn't walk normally) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. A (S or 5) 7164B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In September 2022, the patient experienced DIZZINESS (feeling dizzy), VERTIGO (vertigo/spinning), GAIT DISTURBANCE (couldn't walk normally) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything). At the time of the report, DIZZINESS (feeling dizzy), VERTIGO (vertigo/spinning), GAIT DISTURBANCE (couldn't walk normally) and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything) had resolved.            The patient had no concomitant medications.  It was reported that patient experienced the events 10 hours after receiving the bivalent booster dose and condition was worst when patient lay down.  No treatment information provided.
Information has been received from a licensed practical nurse concerning a female in her 60's with an allergy to tetracycline who on 09-MAR-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) (MSD). It was reported that the nurse "grabbed the wrong one because of the VAX in both names." Unspecified medical attention was sought. The patient had no adverse events. There was no product complaint involved. No further information was provided. Additional information has been requested.
Per mom after immunizations on 11/30/07 child had diarrhea and on/off fever up to 103 for 3 days. Mom reported this to our office on 12/07/07.
Fever; Pain in chest; Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 17-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for 1 day for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for Covid-19 immunization. The following information was reported: PYREXIA (non-serious), outcome "unknown", described as "Fever"; CHEST PAIN (non-serious), outcome "unknown", described as "Pain in chest"; DIZZINESS (non-serious), outcome "unknown", described as "Dizzy". Therapeutic measures were taken as a result of pyrexia.  Additional information: The patient has taken Tylenol for the treatment of fever.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Took vaccine on Thursday: the following Sunday I was nausea/vomiting/ migraine/ weak/ near syncope. Had red raised rash with itching over my arms, chest and stomach. Took Benadryl 50mg without relief. The rash persisted for approximately 2 weeks but the itching subsided after a couple of day. Then end of January developed lymphadenopathy. Went to urgent care and received Augmentin for parotic gland the size of a golf ball and swollen lymph nodes in my neck by my primary doctor a week later.
An hour after getting the shot he got a headache and then started throwing up. The headache and throwing up last on and off for almost a month he then had a seizure and was diagnosed with ADEM on 1/14/16.
Arm where the Pneumococcal Conjugate vaccine was injected swelled from shoulder to elbow to 1.5x its normal size. The area was visibly red and very hot with a line mapping out the entire area on the bottom side of the arm.
12/1/06 C/O stiffness and tenderness in her "muscle" at base of neck, posteriorly and between shoulders.  12/2/06 Pain became severe and worse yet on 12/3/06.  12/4 and 12/5: still "very sore but a little better."  Tylenol, Motrin and heating pad didn't help.  States injection site not sore, no redness, did not develop a fever.  No problem with previous flu shots.  Instructed to try applying ice to area, but to call private provider is discomfort is severe.  Recovered approx. December 27th, 2006.
Redness on left thigh with induration at site of flu shot, hypersensitivity; Redness on left thigh with induration at site of flu shot; Redness on left thigh with induration at site of flu shot; Based on follow-up information received on 05-Nov-2019, this case now become a valid case (patient identifier was reported).  Initial information received on 07-Oct-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2019SA279683.  This case involves a 2 years old female patient who experienced vaccination site hypersensitivity while she received vaccine INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (Fluzone).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 02-OCT-2019, patient received a 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (lot UJ223AA, expiry date: 30-Jun-2020) via intramuscular route in the left vastus lateralis.  On 02-OCT-2019, the patient experienced redness on left thigh with induration at site of flu shot (vaccination site hypersensitivity) same day following the administration of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED.  Other relevant tests included no lab data was provided.  Final diagnosis was redness on left thigh with induration at site of flu shot.   The patient was treated with ibuprofen (Ibuprofen) and ice.  The patient was recovered from event on 04 Oct 2019.  Additional information received on 05-Nov-2019 regarding an unsolicited valid non-serious case received from a nurse.  Gender was updated, case classification was updated and dose regimen of the Vaccine was updated. Events were added. Outcome updated, Treatment medication was added.
Patient received 2 vaccines on 09/20/18 both in left arm due to injury in muscle of right arm. Patient wanted to get both the same day. He was given the PNEUMOVAX 23 on top and the FLUZONE HD on bottom of the deltoid muscle in the left arm on 09/20/18. On 09/20/18 at around 8-9 he noticed severe swelling of the arm and applied ice as instructed if any issues occur. Then he exhibited more swelling and radiating pain down his arm. For the next few days, the arm stayed a little red and inflamed. He had a normal appointment with his PCP two days after the shot. The physician noticed the arm was red and swollen and asked what happened. He mentioned he received a 2 shots in his arm and the MD stated he had an allergic reaction to one of the vaccinations. He did not prescribe any antibiotics for the swelling or redness. On administration, it should be noted nitrile gloves were used since the patient is allergic to latex. Patient was given a rx for Prednisone 10mg take one tablet once daily for another issue and he believes the steroids may have helped with resolving the adverse reaction.
Patient then reported that she had a lot of side effects from the first dose.. Patient reported that she felt dizzy 15 minutes after receiving the vaccine. Patient stated that when she got home from receiving the vaccine that she "passed out" on the couch for the night.  The next morning, the patient broke out in a rash on her feet and legs.  Patient took benadryl and this seemed to help her rash go away.
Pt arrived to observation room  in her own  wheelchair with family members after receiving Covid vaccination. At 25 minutes into 30 min observation she c/o feeling warm, itchy and headache. No rash noted, denied SOB/difficulty breathing. PT states was reluctant to receive vaccine but MD urged her to do so. Pt AO x 3 and verbalized consent for care.. PT given vaccine education. No redness or swelling noted at injection site.   0931 pt given 50mg diphenhydramine PO  0934 O2sat 99%, HR 61  0937 BP 122/68  0942 HR 60, O2sat 99%.   encouraged pt to remain an additional 30 mins in observation but declined to stay but states "I think I will be fine."; pt and family educated on ED protocols. PT left in wheelchair with family member
Approx. 15 min after receiving vaccine, patient c/o itching along his back and chest which progressed to his arms and head. Small area of urticaria noted along back (likely secondary to scratching). Patient was given 50 mg of Benadryl.  Denied any cp/palp/sob./fever/chills/dysphagia. His heart rate was slightly elevated (HR=91-100) but BP remained wnl (123/82). His 02 saturation in room air remained 99%. Patient was monitored with serial vitals for 2 hours and discharged home with instructions regarding contacting 911 or go to nearest ER if symptoms returned/worsen. Next day, patient return to clinic, symptoms resolved, exam was wnl. Patient advised to f/u with immunologist/allergist for evaluation if safe to receive Dose 2 in 21-42 days. In the interim, patient was advised not to receive the second dose unless cleared by Allergist/Immunology provider.
Paresthesia in lower extremities, hands and mouth worse upon waking improves thoughout the day. Started after getting vaccines.
Third dose Pfizer covid 19 vaccine inadvertently given earlier than recommended. No adverse outcomes. Parent will be made aware.
Diagnosed with COVID; fever; fatigue; a little cough; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (a little cough), COVID-19 (Diagnosed with COVID), PYREXIA (fever) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN CALCIUM (LIPITOR), TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), LOSARTAN and RANITIDINE for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced COUGH (a little cough), PYREXIA (fever) and FATIGUE (fatigue). On 16-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID). At the time of the report, COUGH (a little cough), COVID-19 (Diagnosed with COVID), PYREXIA (fever) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol    Reporter did not allow further contact
Complaint of cough, chills, elevated temperature, headache, runny nose, congestion, myalgia and malaise.
About a month after my booster shot I started noticing a hive like reaction on my skin.  I would have sustained itchiness throughout the day and then if a scratched (even gently) or had any type of abrasion with my skin (i.e. drying with a towel post shower) I would have raised red lines on my skin.  The closest thing I could find is called Dermatographia.  I began taking generic allergy medicine which I don't normally take and that has alleviated the itchiness but not the actual red markings.  Both primary series shots were Moderna; however, I did not have this reaction until after my booster.
pt admitted to hosp with acute respiratory failure; found to be positive for COVID; COVID pneumonia; given remdesivir;  O2 supplementation; hypoxia worsened; CXR showed worsening pneumonia; transferred to ICU; required intubation; condition worsened; pt was made a DNR and extubated; pt expired in the hospital
1 fluid filled blister. It was clear blister on Wednesday 10/4. By 10/6 it became slightly deflated and changed to a yellow color.
fall; patient was erroneously administered Adacel twice, with each injection being 4 months apart; Initial information received on 09-Jun-2021 regarding an unsolicited valid non-serious case from a nurse and physician via Media Information (under reference id 00634153).  This case involves a 60 years old female patient who had a fall, after receiving DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was reported that no other vaccines were given to the patient.  On 04-Feb-2021, the patient received 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (solution for injection, total, lot C5687AA, expiry date :09-Dec-2021) via intramuscular route in the left deltoid for prophylactic vaccination.  On 05-Jun-2021, the patient had a fall (non serious event, 4 months 1 day latency following the start dose of adacel) and went to the emergency room after that and received 0.5 ml dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE during that visit (solution for injection, total, lot: U6900AA,expiry date :18-Nov-2022) via intramuscular route in the right deltoid for prophylactic vaccination. And thus was erroneously administered with adacel twice (inappropriate schedule of product administration, on the same day following the last dose).  It was a case of an actual medication error due to drug dose administration interval too short.  It was reported by the caller(nurse), that a patient was administered two injections of ADACEL over a 4 month time frame and would like to know any contraindications or adverse events as a result of this error. It was reported that this case was placed in proxy as there was no one available during the time of the attempted transfer. Call back was needed for assistance. Also the nurse stated that consumer is doing well.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
DIZZINESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of dizziness was not reported. This report was non-serious.
screaming pain in the immediate few days after  vaccination, but not during/immediately, has not resolved in almost six months. aggravated with certain movements. midpoint raising of arm is difficult. some yoga positions are hard. not in joint, but in nerve or tendon in mid-arm area.
47 years old patient received a dose of garadsil 9; This spontaneous report was received from a registered nurse referring to a 47-year-old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On 06-DEC-2019 the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # 1621934 expiry date 29-JAN-2022, 1 dose for prophylaxis (route was not reported) (product administered to patient of inappropriate age). The product quality complaint was not involved.